338 related articles for article (PubMed ID: 17208569)
1. Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis.
Feng J; Besner GE
J Pediatr Surg; 2007 Jan; 42(1):214-20. PubMed ID: 17208569
[TBL] [Abstract][Full Text] [Related]
2. Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats.
Feng J; El-Assal ON; Besner GE
J Pediatr Surg; 2006 Jan; 41(1):144-9; discussion 144-9. PubMed ID: 16410124
[TBL] [Abstract][Full Text] [Related]
3. Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis.
Feng J; El-Assal ON; Besner GE
Semin Pediatr Surg; 2005 Aug; 14(3):167-74. PubMed ID: 16084404
[TBL] [Abstract][Full Text] [Related]
4. Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis.
Feng J; El-Assal ON; Besner GE
J Pediatr Surg; 2006 Apr; 41(4):742-7; discussion 742-7. PubMed ID: 16567187
[TBL] [Abstract][Full Text] [Related]
5. Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis.
Dvorak B; Khailova L; Clark JA; Hosseini DM; Arganbright KM; Reynolds CA; Halpern MD
J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):11-8. PubMed ID: 18607263
[TBL] [Abstract][Full Text] [Related]
6. Heparin-binding EGF-like growth factor increases intestinal microvascular blood flow in necrotizing enterocolitis.
Yu X; Radulescu A; Zorko N; Besner GE
Gastroenterology; 2009 Jul; 137(1):221-30. PubMed ID: 19361505
[TBL] [Abstract][Full Text] [Related]
7. HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation.
El-Assal ON; Besner GE
Gastroenterology; 2005 Aug; 129(2):609-25. PubMed ID: 16083716
[TBL] [Abstract][Full Text] [Related]
8. Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury.
Pillai SB; Hinman CE; Luquette MH; Nowicki PT; Besner GE
J Surg Res; 1999 Dec; 87(2):225-31. PubMed ID: 10600353
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis.
Clark JA; Lane RH; Maclennan NK; Holubec H; Dvorakova K; Halpern MD; Williams CS; Payne CM; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G755-62. PubMed ID: 15528252
[TBL] [Abstract][Full Text] [Related]
10. Timing, route, and dose of administration of heparin-binding epidermal growth factor-like growth factor in protection against intestinal ischemia-reperfusion injury.
Martin AE; Luquette MH; Besner GE
J Pediatr Surg; 2005 Nov; 40(11):1741-7. PubMed ID: 16291163
[TBL] [Abstract][Full Text] [Related]
11. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.
Clark JA; Doelle SM; Halpern MD; Saunders TA; Holubec H; Dvorak K; Boitano SA; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G938-49. PubMed ID: 16798726
[TBL] [Abstract][Full Text] [Related]
12. Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis.
Yang J; Watkins D; Chen CL; Bhushan B; Zhou Y; Besner GE
J Am Coll Surg; 2012 Oct; 215(4):534-45. PubMed ID: 22819639
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model.
Dvorak B; Halpern MD; Holubec H; Williams CS; McWilliam DL; Dominguez JA; Stepankova R; Payne CM; McCuskey RS
Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G156-64. PubMed ID: 11751169
[TBL] [Abstract][Full Text] [Related]
14. Post-ischemic administration of heparin-binding epidermal growth factor-like growth factor (HB-EGF) reduces infarct size and modifies neurogenesis after focal cerebral ischemia in the rat.
Jin K; Sun Y; Xie L; Childs J; Mao XO; Greenberg DA
J Cereb Blood Flow Metab; 2004 Apr; 24(4):399-408. PubMed ID: 15087709
[TBL] [Abstract][Full Text] [Related]
15. Heparin-binding EGF-like growth factor preserves mesenteric microcirculatory blood flow and protects against intestinal injury in rats subjected to hemorrhagic shock and resuscitation.
El-Assal ON; Radulescu A; Besner GE
Surgery; 2007 Aug; 142(2):234-42. PubMed ID: 17689691
[TBL] [Abstract][Full Text] [Related]
16. Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury.
Xia G; Martin AE; Besner GE
J Pediatr Surg; 2003 Mar; 38(3):434-9. PubMed ID: 12632363
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide inhibits enterocyte migration through activation of RhoA-GTPase in a SHP-2-dependent manner.
Cetin S; Leaphart CL; Li J; Ischenko I; Hayman M; Upperman J; Zamora R; Watkins S; Ford HR; Wang J; Hackam DJ
Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1347-58. PubMed ID: 17272518
[TBL] [Abstract][Full Text] [Related]
18. Heparin-binding EGF-like growth factor decreases neutrophil-endothelial cell interactions.
Rocourt DV; Mehta VB; Wu D; Besner GE
J Surg Res; 2007 Aug; 141(2):262-6. PubMed ID: 17574583
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma inhibits intestinal restitution by preventing gap junction communication between enterocytes.
Leaphart CL; Qureshi F; Cetin S; Li J; Dubowski T; Baty C; Beer-Stolz D; Guo F; Murray SA; Hackam DJ
Gastroenterology; 2007 Jun; 132(7):2395-411. PubMed ID: 17570214
[TBL] [Abstract][Full Text] [Related]
20. Expression of HB-EGF by retinal pigment epithelial cells in vitreoretinal proliferative disease.
Hollborn M; Iandiev I; Seifert M; Schnurrbusch UE; Wolf S; Wiedemann P; Bringmann A; Kohen L
Curr Eye Res; 2006 Oct; 31(10):863-74. PubMed ID: 17050278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
